2-Year U.S. Treasury Note Continuous Contract $102.688 0.090 0.09% 5-Year U.S. Treasury Note Continuous Contract $106.664 0.164 0.15% 10-Year U.S. Treasury Note Continuous Contract $109.625 0.203 ...
2-Year U.S. Treasury Note Continuous Contract $102.578-0.020-0.02% 5-Year U.S. Treasury Note Continuous Contract $106.461-0.039-0.04% 10-Year U.S. Treasury Note Continuous Contract $109.391-0.031 ...
The Dow Jones Industrial Average surged more than 1,300 points Wednesday morning as investors registered enthusiasm for a second Donald Trump presidency.
New York ,NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- WorldInvest.org Achieves Global Recognition with Nasdaq Display. WorldInvest.org, a leading online financial platform, marked a major milestone in its ...
Received 3 Rare Pediatric Disease Designations (RPDD) from FDA for each of 3 potential therapies for 3 different rare inherited retinopathies ...
Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...
Since the poll was conducted, Dogecoin smashed through the 42 cent level, hitting a new one-month and one-year high of $0.4359. That means that right now the people who picked 42 cents are correct and ...
High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one pediatric patient as of data ...
Enrolled 4 patients in Cohort 2 of the upliFT-D trial for FTD-GRN, with patient dosing advancing as planned; 12-month Cohort 1 and interim Cohort ...
RJVA-002 is a locally administered AAV9 viral vector that expresses human GIP and GLP-1 hormones from a human insulin promoter. We are confident that our novel pipeline will position us among the ...
Apple's stock, which has had a good year but is under pressure of late, fell after hours Thursday on the company's solid but hardly dazzling quarterly results.
(Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, today announced the pricing of senior unsecured notes in an aggregate ...